Tyrosinemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5011
4 Genes
Common Hereditary Cancer Screening Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15723
55 Genes
PGmax™ - Intellectual Disability, Epilepsy, and Autism (IDEA) Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 5045
2527 Genes
Tooth Agenesis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3021
9 Genes
Elevated Levels of C5-hydroxyacylcarnitine (C5-OH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4999
7 Genes
Lynch Syndrome via MLPA of PMS2
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 6062
1 Gene
Bernard-Soulier Syndrome via the GP9 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9227
1 Gene
PGmax™ - Comprehensive Inherited Metabolic Disorders and Mitochondrial Disorders (Nuclear Genes only) Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 16006
1317 Genes
Angelman/Prader Willi Syndrome by MS-MLPA
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification
2 - 3 weeks (6 - 11 days STAT)•Test 2056
2 Genes
Branchiootorenal Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10115
3 Genes
Maturity Onset Diabetes of the Young (MODY) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10305
18 Genes
Familial Partial Lipodystrophy (FPLD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12605
16 Genes
Long QT Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10325
19 Genes
Hereditary Hemochromatosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10243
7 Genes
3-Methylcrotonyl-CoA Carboxylase Deficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 10069
2 Genes
Alport Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10147
4 Genes
Nevoid Basal Cell Carcinoma Syndrome Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16205
3 Genes
PGxome® - Rapid Whole Exome Test
Exome Platform with CNV
7 - 16 days•Test 13001
Alzheimer's Disease, Familial, Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3409
3 Genes
Interstitial Lung Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5211
24 Genes
PGmax™ - Comprehensive Congenital Heart Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 13008
509 Genes
Familial Hypercholesterolemia (FH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10163
8 Genes
Autosomal Recessive Polycystic Kidney Disease (ARPKD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10463
3 Genes
Generalized Arterial Calcification of Infancy and Pseudoxanthoma Elasticum (PXE) via the ABCC6 Gene
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7857
1 Gene
Glycogen Storage Disease Type II (Pompe Disease) via the GAA Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 223
1 Gene
Leber Hereditary Optic Neuropathy (LHON) - Targeted Testing for 3 Common Pathogenic Variants
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 15667
3 Genes
Congenital Abnormalities of the Kidney and Urinary Tract (CAKUT) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2667
77 Genes
Alagille Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10071
2 Genes
Alzheimer's Disease, Familial, Plus APOE Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15781
4 Genes
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)/Dysplasia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 10261
18 Genes
Autoimmune Lymphoproliferative Syndrome/ALPS Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4921
16 Genes
Cardiac Arrhythmia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10423
68 Genes
Autosomal Dominant and Recessive Polycystic Kidney Disease (ADPKD and ARPKD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10189
13 Genes
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10149
10 Genes
Bardet-Biedl Syndrome (BBS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 10349
27 Genes
Familial Hemiplegic Migraine Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10161
8 Genes
Breast Cancer - High Risk Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5431
7 Genes
Brugada Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10329
17 Genes
Catecholaminergic Polymorphic Ventricular Tachycardia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10249
11 Genes
Cerebral Cavernous Malformations Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 1943
3 Genes
Chronic Pancreatitis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10191
7 Genes
Coffin-Siris Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10221
12 Genes
Chronic Progressive External Ophthalmoplegia (CPEO/PEO) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10507
13 Genes
GJB2 Regulatory Element Deletion Testing (GJB6-D13S1830 and GJB6-D13S1854)
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 2997
1 Gene
Adrenocortical Carcinoma (ACC) Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16213
8 Genes
Combined Pituitary Hormone Deficiency (CPHD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5287
9 Genes
Adams-Oliver Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13027
8 Genes
Polycystic Liver Disease (PLD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10227
8 Genes
Inozyme ABCC6 Deficiency Genetic Test Program
Sponsored TestNGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7857
1 Gene
Comprehensive Vitreoretinopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7941
21 Genes
Autism Spectrum Disorders (ASD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5061
170 Genes
PGmax™ - Inborn Errors of Immunity/Primary Immunodeficiency (PID) Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 13999
640 Genes
Charcot-Marie-Tooth (CMT) - Comprehensive Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10419
83 Genes
Hypertrophic Cardiomyopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1313
68 Genes
PGnome® - Health Screen Genome Test
Genome Platform with SV
3 - 5 weeks•Test 9000
Severe Congenital Neutropenia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10257
42 Genes
Ambiguous Genitalia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 6903
85 Genes
PGmito - Mitochondrial Genome Sequencing
Long Range PCR and NGS
3 - 4 weeks•Test 12980
37 Genes
Protein C Deficiency via the PROC Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8493
1 Gene
Movement Disorder Genetic Test Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 16004
938 Genes
Oculocutaneous Albinism Type 2 (OCAII) via the OCA2 Known Intragenic Gross Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 3738
1 Gene
Lynch Syndrome via the MSH2 Exons 1-7 Inversion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 906
1 Gene
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10359
38 Genes
Beta-Thalassemia and Hemoglobinopathy via the HBB Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7693
1 Gene
Cell Cultures
Cell cultures are performed by Allele Diagnostics
N/A•Test 995
Targeted Testing for Sequence Variants
Sanger Sequencing
2 - 3 weeks (6 - 14 days STAT)•Test 100
Ehlers-Danlos Syndromes (EDS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10383
65 Genes
LHCGR-related Disorders via the LHCGR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7729
1 Gene
Amyotrophic Lateral Sclerosis / Motor Neuron Disease via the FUS Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 6927
MATERNAL CELL CONTAMINATION TESTING
Sponsored TestSanger Sequencing
3 weeks (STAT 2 weeks)•Test 1150
Rett Syndrome via the MECP2 Gene
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7271
1 Gene
Parkinson Disease via the LRRK2 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11457
1 Gene
Manitoba Oculotrichoanal Syndrome (MOTA) via the FREM1 Exon 8-23 Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 3782
1 Gene
Galactosemia Type I (Classic and Variant Galactosemia) via the GALT Gene, 5.5 kb Common Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 2310
1 Gene
Hermansky-Pudlak Syndrome via the HPS3 Gene, Exon 1 Deletion
Targeted Deletion
2 - 3 weeks (8 - 10 days STAT)•Test 759
1 Gene
Targeted Variants - Mitochondrial Genome Testing
Long Range PCR and NGS
2 - 3 weeks•Test 14028
Paroxysmal Paralytic Rhabdomyolysis via the LPIN1 Gene, Exons 18-19 Deletion
Targeted Deletion
2 - 3 weeks (8 - 10 days STAT)•Test 319
1 Gene
Targeted Variants - Deletion/Duplication Testing
Targeted PCR
2 - 3 weeks•Test 1400
Congenital Central Hypoventilation Syndrome (CCHS) via the PHOX2B Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8967
Peroxisomal Biogenesis Disorder-Zellweger Spectrum Disorder (PBD-ZSD) Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 12655
13 Genes
No-Cost Genetic Testing Program for Thymidine Kinase 2 Deficiency
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 12031
55 Genes
X-Linked Adrenoleukodystrophy (X-ALD) Newborn Screening Reflex Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 12670
26 Genes
Early-Onset Bilateral Cataracts Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 13315
66 Genes
Ionis Familial Chylomicronemia Syndrome (FCS) Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13025
7 Genes
No-Cost Genetic Testing Program for Thymidine Kinase 2 Deficiency
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 12029
1 Gene
POMC/PCSK1/LEPR CDx Panel
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 13067
3 Genes
Amyotrophic Lateral Sclerosis (ALS) Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 15479
29 Genes
CardioNavigATTR Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 16207
36 Genes
NeuroNavigATTR Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 16209
66 Genes
Xeris Pharmaceuticals Uncovering Periodic Paralysis
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 16099
6 Genes
Alnylam Act® Primary Hyperoxaluria Type 1 Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 16035
45 Genes
NavigATTR Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 15139
1 Gene
Decode DEB Sponsored Testing Program
Sponsored TestSequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 15787
27 Genes
Amplify™ Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 15747
269 Genes
No-Cost Genetic Testing Program for Friedreich Ataxia (FA)
Sponsored TestRepeat-Primed PCR and Fragment Length Assay
1 - 2 weeks (6 - 9 days STAT)•Test 20060
1 Gene
Alnylam Act® Acute Hepatic Porphyria Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 16301
10 Genes
My Retina Tracker Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 16023
110 Genes
PassageBio FTD
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 5265
19 Genes
Alnylam Act® Primary Hyperoxaluria Type 1 Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 16029
3 Genes
Sponsored Genetic Testing Program for Cholestasis
Sponsored TestNGS with CNV (PGselect Platform)
3 weeks (STAT 2 weeks)•Test 15215
77 Genes
Cerebral Cavernous Malformations via the KRIT1/CCM1 Gene, Exon 10
Sanger Sequencing
3 - 4 weeks (12 - 19 days STAT)•Test 125
1 Gene
PGxome® - Whole Exome Test
Exome Platform with CNV
3 - 5 weeks•Test 5000
Allan-Herndon-Dudley Syndrome or Monocarboxylate Transporter 8 Deficiency via the SLC16A2 Gene
Sanger Sequencing
3 - 4 weeks (12 - 19 days STAT)•Test 2086
1 Gene
Idiopathic Hypogonadotropic Hypogonadism (IHH) via the GNRHR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9113
1 Gene
Homocystinuria via the CBS Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9369
1 Gene
Ectodermal Dysplasia via the EDA Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7631
1 Gene
Whole Genome Chromosomal Microarray (CMA-ISCA)
CMA
3 - 5 weeks•Test 2000
Rapid Prenatal Whole Genome Chromosomal Microarray (CMA-ISCA) Test
CMA
6 - 10 days•Test 3780
Neuroblastoma Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 5057
15 Genes
Gitelman Syndrome via the SLC12A3 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4503
1 Gene
Optic Atrophy and Hereditary Spastic Paraplegia via the SPG7 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11707
1 Gene
PTEN Hamartoma Tumor Syndrome via the PTEN Gene
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 7513
1 Gene
Congenital Defects of Phagocytes Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16091
43 Genes
Congenital Adrenal Hyperplasia (CAH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12053
7 Genes
Parkinson Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10337
24 Genes
Deafness, Autosomal Recessive 9 (DFNB9) via the OTOF Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11549
1 Gene
Susceptibility to Infection Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16093
64 Genes
Combined Immunodeficiencies with Syndromic Features Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16097
67 Genes
Comprehensive Endocrine Cancer Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16211
42 Genes
Complement Deficiencies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16089
26 Genes
Immune Dysregulation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16095
59 Genes
Antibody Deficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16083
41 Genes
Cellular and Humoral Immunodeficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16087
62 Genes
Fibrodysplasia Ossificans progressiva (FOP) via the ACVR1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8293
1 Gene
X-Linked Hypoparathyroidism via the Interstitial Deletion-Insertion Involving Chromosomes 2p25.3 and Xq27.1, Near SOX3
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 4201
1 Gene
Autoinflammatory Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16085
57 Genes
Sarcoma Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7971
35 Genes
Hereditary Central Nervous System/Brain Cancer Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7969
26 Genes
PGmax™ - Skeletal Disorders and Joint Problems Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 10631
694 Genes
PGxome® - Prenatal Whole Exome Test
Exome Platform with CNV
7 - 16 days•Test 14010
Extract and Hold
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 14033
PGnome® - Whole Genome Test
Genome Platform with SV
3 - 5 weeks•Test 7000
Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 3005
17 Genes
Friedreich Ataxia (FRDA) via the FXN GAA Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 20060
1 Gene
Elevated Levels of C14 and C14:1 Acylcarnitine via the ACADVL Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16043
1 Gene
Elevated Levels of C6, C8 and C10 Acylcarnitine via the ACADM Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16045
1 Gene
Hyperphenylalaninemia/Phenylalanine Hydroxylase Deficiency via the PAH Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9725
1 Gene
PGmax™ - Comprehensive Epilepsy and Seizure Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 16005
1455 Genes
PGxome® - Health Screen Exome Test
Exome Platform with CNV
3 - 5 weeks•Test 4000
No-charge Sponsored Testing Program for Rare Genetic Diseases of Obesity
Sponsored TestNGS with CNV (PGselect Platform)
3 weeks (STAT 2 weeks)•Test 15187
87 Genes
Gene-Centric CNV Analysis via aCGH
CNV via aCGH
2 - 4 weeks (9 - 21 days STAT)•Test 600
Rapid Whole Genome Chromosomal Microarray (CMA-ISCA) Test
CMA
6 - 10 days•Test 12684
Comprehensive Brain Malformation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12619
336 Genes
Elevated Levels of C0/(C16+C18) Acylcarnitine via the CPT1A Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16041
1 Gene
Low Levels of Free Carnitine (C0) via the SLC22A5 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 16039
1 Gene
Hypoglycemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12057
171 Genes
Glucose-6-Phosphate Dehydrogenase Deficiency via the G6PD Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7657
1 Gene
Severe Skeletal Conditions Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15771
85 Genes
Ectodermal Dysplasia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10223
6 Genes
Dilated Cardiomyopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1339
68 Genes
Thrombocytopenia Panel - Expanded
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10393
33 Genes
Galactosemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5013
4 Genes
Amelogenesis and Dentinogenesis Imperfecta Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (6 - 12 days STAT)•Test 5207
34 Genes
Epilepsy and Seizure Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7347
410 Genes
Hemophilia B via the F9 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7641
1 Gene
Hereditary Hemorrhagic Telangiectasia (HHT) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10131
6 Genes
Glycogen Storage Disease (GSD) and Disorders of Glucose Metabolism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10385
33 Genes
L1 Syndrome via the L1CAM Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7719
1 Gene
Spondylocostal Dysostosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10213
6 Genes
Connective Tissue Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7947
101 Genes
Congenital Limb Malformation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5065
99 Genes
Primary Aldosteronism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3023
4 Genes
Familial Amyloidosis (hATTR) via the TTR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8983
1 Gene
Oculocutaneous Albinism and Hypopigmentation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10313
31 Genes
Differences of Sex Development (DSD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4509
158 Genes
Congenital Adrenal Hyperplasia (CAH) via the CYP21A2 Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 1419
1 Gene
Pulmonary Arterial Hypertension (PAH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12625
11 Genes
Disorders Related to Metabolism of Cobalamin, Folate and Homocysteine Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10397
39 Genes
Cornelia de Lange Syndrome and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10399
42 Genes
TNXB-Related Disorders via the TNXB Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7533
1 Gene
Inherited Bone Marrow Failure Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7359
196 Genes
Nephrotic Syndrome (NS)/Focal Segmental Glomerulosclerosis (FSGS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10417
72 Genes
Androgen Insensitivity Syndrome (AIS) via the Androgen Receptor (AR) Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7577
1 Gene
PGnome® - Rapid Whole Genome Test
Genome Platform with SV
8 - 16 days•Test 14000
Klippel-Feil Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12621
6 Genes
Glaucoma Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10335
24 Genes
No-Charge Genetic Testing and Counseling Program for Sensorineural Hearing Loss
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 to 4 weeks•Test 16033
274 Genes
Dentatorubral-Pallidoluysian Atrophy (DRPLA) via the ATN1 CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 5999
1 Gene
Top 99 Genetic Causes of Developmental Delay Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12675
99 Genes
Osteogenesis Imperfecta Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12047
30 Genes
Disorders of Copper Metabolism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12673
6 Genes
Leukodystrophy and Leukoencephalopathy, Adult Onset Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12623
45 Genes
Cerebral Small Vessel Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12637
10 Genes
Lipodystrophy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12603
29 Genes
Treacher Collins Syndrome/Mandibulofacial Dysostosis/Miller Syndrome/Acrofacial Dysostosis, Nagar Type Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10235
7 Genes
TNXB-Related Disorders via the TNXB Gene, Exons 32-44
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 6088
1 Gene
Non-Immune Hydrops Fetalis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12661
149 Genes
Polydactyly and Syndactyly Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13099
230 Genes
Hereditary Hemolytic Anemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12041
34 Genes
Inherited Platelet Function Disorder Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10371
26 Genes
Amyotrophic Lateral Sclerosis (ALS)/Motor Neuron Disease via the SOD1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8949
1 Gene
DetectHypopara™ Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 15739
26 Genes
Familial Hemophagocytic Lymphohistiocytosis-Type 3 (FHL3) via the UNC13D Inversion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 2050
1 Gene
Wilms Tumor Panel
NGS with CNV (PGselect platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10447
29 Genes
Nonsyndromic Congenital Heart Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13097
44 Genes
Mitochondrial Disorders Panel (Nuclear Genes Only)
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5077
253 Genes
Lysosomal Storage Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13065
146 Genes
Spinocerebellar Ataxia Type 2 via the ATXN2 CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 12976
1 Gene
Marfan Syndrome and Related Aortopathies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10363
40 Genes
Monogenic Diabetes Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4303
54 Genes
Organic Aciduria Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10391
41 Genes
Congenital Anomalies of the Gastrointestinal Tract Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13377
180 Genes
PGmaxTM - Comprehensive Inherited Kidney Diseases Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 13990
330 Genes
VACTERL Association and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13041
84 Genes
Congenital Diaphragmatic Hernia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13359
65 Genes
Hereditary Cystic Kidney Diseases Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10619
48 Genes
Noonan Spectrum Disorders/RASopathies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10327
23 Genes
Anterior Segment Dysgenesis Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12003
278 Genes
Cholestasis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10319
70 Genes
Alnylam Act® hATTR Amyloidosis Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 15139
1 Gene
ENPP1 and ABCC6 Genetic Testing (SP‑051)
Sponsored TestNGS with CNV (Exome or Genome Platform)
3 weeks (STAT 2 weeks)•Test 7555
2 Genes
Strabismus Syndrome or Congenital Fibrosis of Extraocular Muscles (Ocular Motility Disorder) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2685
14 Genes
PGmax™ - Neonatal Crisis Panel
NGS with CNV (Exome or Genome Platform)
7 - 16 days•Test 7383
Familial Chylomicronemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13025
7 Genes
GNAS-Related Disorders via the GNAS Gene
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 15163
1 Gene
Machado-Joseph Disease (MJD)/Spinocerebellar Ataxia Type 3 (SCA3) via the ATXN3 CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 13213
1 Gene
Congenital Diarrhea and Enteropathies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12647
157 Genes
PGmaxTM - Primary Immunodeficiency and Malignancy Predisposition Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 19998
712 Genes
Episodic Ataxia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13383
36 Genes
Oculopharyngeal Muscular Dystrophy via the PABPN1 (GCN) Repeat Expansion
Expansion Assay
1 - 2 weeks (6 - 10 days STAT)•Test 6058
1 Gene
Comprehensive Monogenic Obesity Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15185
52 Genes
Spinocerebellar Ataxia Type 17 via the TBP CAG/CAA Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 6059
1 Gene
Lynch Syndrome/Constitutional Mismatch Repair Deficiency Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 5463
5 Genes
Spinal Muscular Atrophy (SMA) via MLPA of SMN1 and SMN2
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 6064
2 Genes
X-linked Spinal and Bulbar Muscular Atrophy (Kennedy Disease) via the AR Gene CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 7501
1 Gene
Hereditary Breast, Ovarian, Pancreatic, and Prostate Cancer Syndrome BRCA1/2 Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 5451
2 Genes
Crigler-Najjar Syndrome and Gilbert Syndrome via the UGT1A1 Gene
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 7851
1 Gene
C9orf72 Gene Hexanucleotide Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 151
1 Gene
Hereditary Breast and Gynecological Cancer Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 5453
19 Genes
Diamond-Blackfan Anemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3015
23 Genes
Premature Ovarian Failure (POF) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5285
21 Genes
Hypogonadotropic Hypogonadism/Kallmann Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5243
38 Genes
Alpha Thalassemia Panel
Sanger Sequencing and MLPA
3 - 4 weeks (12 - 19 days STAT)•Test 6090
2 Genes
Autosomal Dominant Polycystic Kidney Disease via MLPA of PKD1
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 2058
1 Gene
Lymphedema Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10303
14 Genes
Porphyria Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10255
8 Genes
Alpha Thalassemia Deletion/Duplication and Constant Spring Panel
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 6070
2 Genes
Autosomal Dominant Polycystic Kidney Disease via the PKD1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10453
1 Gene
Biotinidase Deficiency via the BTD Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9551
1 Gene
CADASIL1 via the NOTCH3 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11525
1 Gene
X-linked Retinitis Pigmentosa (XLRP) via the RPGR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11013
1 Gene
Kallmann Syndrome (KS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10279
10 Genes
Periodic Fever Syndromes Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10315
13 Genes
Craniofacial Malformations Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10343
19 Genes
Currarino Syndrome via the MNX1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9829
1 Gene
Schwannomatosis Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 10107
3 Genes
Neurofibromatosis Type 1 (NF1) and Legius Syndrome Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 10099
2 Genes
Infantile Myofibromatosis Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 10091
2 Genes
Birt-Hogg-Dube Syndrome via the FLCN Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8409
1 Gene
Hereditary Multiple Osteochondromas and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10085
6 Genes
Ellis-van Creveld Syndrome (EVC) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10079
2 Genes
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10049
158 Genes
Comprehensive Pediatric Solid Tumor Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 7973
137 Genes
Rubinstein-Taybi Syndrome and Floating-Harbor Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10141
3 Genes
CADASIL and CARASIL Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10073
2 Genes
Comprehensive Neuropathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10427
145 Genes
Neurohypophyseal Diabetes Insipidus and Nephrogenic Diabetes Insipidus Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10137
3 Genes
Xeroderma Pigmentosum (XP) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10259
9 Genes
von Willebrand Disease Types 1, 2, and 3 via the VWF Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 11801
1 Gene
Female Infertility Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4513
105 Genes
Parkinson Disease and Parkinsonism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10623
70 Genes
Congenital Stationary Night Blindness Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4319
17 Genes
Corneal Dystrophies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3029
27 Genes
Multiple Endocrine Neoplasia Type 2A (MEN2A), Type 2B (MEN2B), and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 4673
1 Gene
IRF6-Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12081
2 Genes
Hypermethioninemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10133
4 Genes
Hereditary Myelodysplastic Syndrome (MDS) / Acute Myeloid Leukemia (AML) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10293
12 Genes
Multiple Epiphyseal Dysplasia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10247
10 Genes
Neurodegeneration with Brain Iron Accumulation Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2695
16 Genes
Inherited Retinal Dystrophies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4379
363 Genes
Stargardt Disease (STGD) and Macular Dystrophies Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4315
28 Genes
Kabuki Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10173
9 Genes
Peroxisomal Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10369
27 Genes
Leukodystrophy and Leukoencephalopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5495
212 Genes
Bleeding Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10425
85 Genes
Comprehensive Hereditary Cancer Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5471
117 Genes
Cleft Lip/Cleft Palate Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10657
165 Genes
Comprehensive Neuromuscular Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10433
266 Genes
Gaucher Disease via the GBA1/GBA Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 479
1 Gene
Iron-Refractory Iron Deficiency Anemia (IRIDA) via the TMPRSS6 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8027
1 Gene
Congenital Methemoglobinemia via the CYB5R3 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9947
1 Gene
Protein S Deficiency via the PROS1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9901
1 Gene
Ornithine Transcarbamylase Deficiency via the OTC Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9723
1 Gene
Short Chain Acyl-CoA Dehydrogenase Deficiency via the ACADS Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8461
1 Gene
Retinoblastoma via the RB1 Gene
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 4501
1 Gene
Holt-Oram Syndrome (HOS) via the TBX5 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8475
1 Gene
SHOX-Related Disorders via the SHOX Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 626
1 Gene
Glycogen Storage Disease Type Ia via the G6PC1/G6PC Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9601
1 Gene
Cystinosis via the CTNS Gene, 57-kb Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 1636
1 Gene
Nemaline Myopathy via the NEB Exon 55 Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 356
1 Gene
Cerebral Cavernous Malformations via the CCM2 Gene, Exons 2-10 Deletion
Targeted PCR
3 weeks (STAT 2 weeks)•Test 124
1 Gene
Von Hippel-Lindau Disease via VHL Gene
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 7523
1 Gene
Maple Syrup Urine Disease Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3281
3 Genes
Multiple Endocrine Neoplasia Type 1 via the MEN1 Gene
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 7503
1 Gene
Thrombocytopenia Absent Radius (TAR) Syndrome via the RBM8A 1q21.1 Deletion
CMA
3 - 5 weeks (6 - 10 days STAT)•Test 1718
1 Gene
Nemaline Myopathy via the NEB Gene, Exons 82-105 (Triplicate Repeat Region)
Sanger Sequencing
3 - 4 weeks (12 - 19 days STAT)•Test 2079
1 Gene
Inherited Ichthyoses and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4929
68 Genes
Thrombocytopenia Absent Radius (TAR) Syndrome via the RBM8A Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 1721
1 Gene
Congenital Hypothyroidism and Thyroid Hormone Resistance Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1989
26 Genes
Krabbe Disease via the GALC Exons 11-17 (502T/Del)
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 632
1 Gene
Beckwith-Wiedemann Syndrome via the CDKN1C Gene
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10005
1 Gene
Tay-Sachs Disease via the French Canadian Deletion in the HEXA Gene
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 1450
1 Gene
Comprehensive Arrhythmia and Cardiomyopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2663
169 Genes
Trimethylaminuria via the FMO3 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8503
1 Gene
Hypomagnesemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3025
16 Genes
Retinitis Pigmentosa Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2699
82 Genes
Niemann-Pick Disease Type C Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 3425
2 Genes
Hypoparathyroidism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2653
28 Genes
Neuronal Ceroid Lipofuscinosis 3 (Batten Disease) via the CLN3 c.461-280_677+382 Deletion
Targeted PCR
3 weeks (STAT 2 weeks)•Test 3739
1 Gene
Leber Congenital Amaurosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4313
28 Genes
Propionic Acidemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3291
2 Genes
Cystic Fibrosis and CF-Related Disorders via the CFTR Gene
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 3035
1 Gene
PMP22-Related Neuropathies via the PMP22 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9033
1 Gene
Glycogen Storage Disease Type II (Pompe Disease) via the GAA Gene, Exon 18 Deletion
Targeted PCR
2 - 3 weeks (8 - 10 days STAT)•Test 234
1 Gene
Y Chromosome Deletion Analysis
Targeted Deletion
2 - 3 weeks (8 - 10 days STAT)•Test 3740
1 Gene
Hemophilia A via the F8 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3077
1 Gene
Factor VII Deficiency via the F7 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4149
1 Gene
Huntington Disease via the HTT CAG Repeat Expansion
Repeat-Primed PCR & Fragment Length
1 - 2 weeks (6 - 10 days STAT)•Test 2299
1 Gene
Primary Hyperoxaluria Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4531
3 Genes
Nemaline Myopathy (NEM2) via the Nebulin (NEB) Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1772
1 Gene
Severe MTHFR Deficiency via the MTHFR Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7291
1 Gene
Mitochondrial Trifunctional Protein Deficiency and Long-Chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10635
2 Genes
Tuberous Sclerosis Complex (TSC) Deletion/Duplication Testing via MLPA
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 2055
2 Genes
Tuberous Sclerosis Complex (TSC) Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 10661
2 Genes
Generalized Arterial Calcification of Infancy (GACI) and Pseudoxanthoma Elasticum (PXE) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7545
2 Genes
Marfan Syndrome via the FBN1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3057
1 Gene
Glycogen Storage Disease Type IV via the GBE1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5413
1 Gene
Dystrophinopathy via the DMD Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 1773
Prostate Cancer Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 5459
16 Genes
Fanconi Anemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10361
22 Genes
Melanoma Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 5473
10 Genes
Loeys-Dietz Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15737
6 Genes
Distal Arthrogryposis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10289
12 Genes
Hemophilia C via the F11 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7079
1 Gene
Hypospadias Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 6905
73 Genes
DICER1 Syndrome via the DICER1 Gene
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 3041
1 Gene
Hyperphenylalaninemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3403
6 Genes
Shwachman-Diamond Syndrome via the SBDS Gene
Sanger Sequencing
3 - 4 weeks (12 - 19 days STAT)•Test 1289
1 Gene
Fabry Disease via the GLA Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7681
1 Gene
Wilson Disease / Hepatolenticular Degeneration via the ATP7B Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7871
1 Gene
Butyrylcholinesterase Deficiency via the BCHE Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7873
1 Gene
Canavan Disease (Aspartoacylase Deficiency) via the ASPA Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9533
1 Gene
Short Rib Skeletal Dysplasia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10347
19 Genes
Hypophosphatasia via the ALPL Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7573
1 Gene
X-Linked Adrenoleukodystrophy via the ABCD1 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7557
1 Gene
Urea Cycle Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10273
9 Genes
Wolfram Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10057
2 Genes
Carnitine Palmitoyltransferase II Deficiency via the CPT2 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 9563
1 Gene
Optic Atrophy and Neuropathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10331
70 Genes
Holoprosencephaly, Autosomal Dominant, Nonsyndromic, Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10317
14 Genes
Congenital Central Hypoventilation Syndrome (CCHS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10239
7 Genes
Waardenburg Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10055
8 Genes
Pendred Syndrome and Nonsyndromic Hearing Loss Associated with Enlarged Vestibular Aqueduct Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10051
3 Genes
Craniosynostosis and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10197
5 Genes
Idiopathic Basal Ganglia Calcification Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10171
4 Genes
Primary Periodic Paralysis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10139
3 Genes
Episodic Pain Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10123
4 Genes
Hereditary Colorectal Cancer and Polyposis Panel
NGS with CNV (PGselect Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5467
25 Genes
Hirschsprung Disease (Non-syndromic) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10225
6 Genes
Pulmonary Fibrosis and Surfactant Dysfunction Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10287
10 Genes
Familial Hemophagocytic Lymphohistiocytosis (FHL) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10377
29 Genes
Congenital Hyperinsulinism Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10265
9 Genes
Congenital Fibrinogen Deficiency Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10119
3 Genes
Nephrolithiasis and Nephrocalcinosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10395
30 Genes
Pantothenate Kinase-Associated Neurodegeneration (PKAN, Hallervorden-Spatz Disease) via the PANK2 Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 8347
1 Gene
Blepharophimosis-Ptosis-Epicanthus Inversus syndrome (BPES) via the FOXL2 Gene
Sanger Sequencing
3 - 4 weeks (12 - 20 days STAT)•Test 1673
1 Gene
Fragile X Syndrome via FMR1 CGG Repeat Expansion
Repeat-Primed PCR & MS-PCR
1 - 2 weeks (6 - 10 days STAT)•Test 558
1 Gene
Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10229
6 Genes
Pseudohypoaldosteronism Type I Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10179
4 Genes
Familial Hypocalciuric Hypercalcemia (FHH) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10125
3 Genes
Cystinuria Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10075
2 Genes
Pediatric Cataracts Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10413
41 Genes
Malignant Hyperthermia Susceptibility Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10059
3 Genes
Distal Renal Tubular Acidosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10159
4 Genes
Hermansky-Pudlak Syndrome (HPS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10269
11 Genes
Epidermolysis Bullosa and Related Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3003
18 Genes
Stickler Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10271
12 Genes
Sterol Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13319
12 Genes
Hereditary Spastic Paraplegia Comprehensive Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 2673
106 Genes
Amyotrophic Lateral Sclerosis (ALS) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10155
29 Genes
PGmax™ - Comprehensive Movement Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 16004
938 Genes
Deafness, Autosomal Recessive 16 (DFNB16) via the STRC Gene
Sanger Sequencing
3 weeks (STAT 2 weeks)•Test 514
1 Gene
Deafness, Autosomal Recessive 16 (DFNB16) via MLPA of STRC
Multiplex Ligation-Dependent Probe Amplification Assay
2 - 3 weeks (6 - 11 days STAT)•Test 12548
1 Gene
Hereditary Paraganglioma and Pheochromocytoma Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 1329
12 Genes
Dystonia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 3017
17 Genes
Congenital Myasthenic Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10321
32 Genes
Hyperammonemia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10407
63 Genes
Neonatal Respiratory Distress Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 13349
5 Genes
Hereditary Diffuse Leukoencephalopathy with Spheroids via the CSF1R Gene
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10665
1 Gene
Glycine Encephalopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10129
11 Genes
Microphthalmia/Anophthalmia/Coloboma Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10333
55 Genes
Hydrocephalus Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 7939
38 Genes
Disorders of Fatty Acid Oxidation (FAOD) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10381
33 Genes
Pan Cardiomyopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5263
117 Genes
Male Infertility Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 4511
137 Genes
Hereditary Ovarian Cancer Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 5469
30 Genes
Pancreatic Cancer Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 5461
18 Genes
Gastric Cancer Panel
Sequencing with CNV PG-Select
2 - 3 weeks (7 - 16 days STAT)•Test 10449
19 Genes
Early-Onset High Myopia Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15487
137 Genes
Bone Fragility and Fracture Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 12679
72 Genes
Hereditary Hearing Loss and Deafness Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 5063
234 Genes
Usher Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10053
12 Genes
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 15423
160 Genes
PGmax™ - Comprehensive Ocular Disorders Panel
NGS with CNV (Exome or Genome Platform)
2 - 4 weeks (7 - 16 days STAT)•Test 12005
644 Genes
Congenital Disorders of Glycosylation (CDG) Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10625
54 Genes
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome and Cystic Fibrosis Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10415
51 Genes
Primary Ciliary Dyskinesia (PCD)/Immotile Cilia Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10411
50 Genes
Heterotaxy, Situs Inversus and Kartagener's Syndrome Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10405
48 Genes
Ciliopathy Panel
NGS with CNV (Exome or Genome Platform)
2 - 3 weeks (7 - 16 days STAT)•Test 10431
133 Genes
Genetic Testing Program for Hypertrophic Cardiomyopathy (HCM)
Sponsored TestSequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 15797
56 Genes
No-Cost Genetic Testing Program for Friedreich Ataxia (FA)
Sponsored Test1 Gene
Targeted Variants - Mitochondrial Genome Testing
Long Range PCR and NGS
3 weeks (STAT 2 weeks)•Test 14028
PGxome Prenatal - Patient Only
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 14010
Orphan Technologies
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 12677
22 Genes
Alnylam Act® Primary Hyperoxaluria Type 1 Sponsored Testing Program
Sponsored Test1 Gene
Alnylam Act® hATTR Amyloidosis Sponsored Testing Program
Sponsored Test1 Gene
Alnylam Act® Acute Hepatic Porphyria Sponsored Testing Program
Sponsored Test1 Gene
NavigATTR Sponsored Testing Program
Sponsored Test1 Gene
Targeted Variants - Triple Exon Sequencing
Sanger Sequencing
3 weeks (STAT 2 weeks)•Test 300
Cell Cultures
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 995
Glutaric Acidemia Type I via the GCDH Gene
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 9617
Limb Girdle Muscular Dystrophy (LGMD) Panel
fdsaf
3 weeks (STAT 2 weeks)•Test 4324324
Limb Girdle Muscular Dystrophy (LGMD) Panel
fdasfa
3 weeks (STAT 2 weeks)•Test
Targeted Variants - Prenatal
Sanger Sequencing
3 weeks (STAT 2 weeks)•Test 990
PGxome® - Rapid Whole Exome Test
Exome Platform with CNV
7 - 16 days•Test 13001
Targeted Variants
Sanger Sequencing
3 weeks (STAT 2 weeks)•Test 100
NeuroNavigATTR Sponsored Testing Program
Sponsored Test1 Gene
CardioNavigATTR Sponsored Testing Program
Sponsored Test1 Gene
Alnylam Act® Primary Hyperoxaluria Type 1 Sponsored Testing Program
Sponsored Test1 Gene
Genetic Testing Program for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Sponsored TestSequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 15795
17 Genes
No-charge Sponsored Testing Program for Rare Genetic Diseases of Obesity
Sponsored Test1 Gene
No-Charge Genetic Testing and Counseling Program for Sensorineural Hearing Loss
Sponsored Test1 Gene
Congenital Muscular Dystrophy (CMD) Panel
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test
28 Genes
Facioscapulohumeral Muscular Dystrophy 2 via the SMCHD1 Gene
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test
1 Gene
Congenital Muscular Dystrophy, Megaconial Type via the CHKB Gene
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test
1 Gene
PGmito - Mitochondrial Genome Sequencing
Long Range PCR and NGS
3 weeks (STAT 2 weeks)•Test 12980
37 Genes
Amplify™ Sponsored Testing Program
Sponsored Test1 Gene
PGxome Diagnostic - Family Duo
Sequencing with CNV PGxome
3 weeks (STAT 2 weeks)•Test 5200
Xeris Pharmaceuticals Uncovering Periodic Paralysis
Sponsored Test1 Gene
No-Cost Genetic Testing Program for Thymidine Kinase 2 Deficiency
Sponsored Test1 Gene
Genetic Testing Program for Hypertrophic Cardiomyopathy (HCM)
Sponsored Test1 Gene
Genetic Testing Program for Activated PI3K Delta Syndrome (APDS)
Sponsored Test1 Gene
Genetic Testing Program for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Sponsored Test1 Gene
POMC/PCSK1/LEPR Companion Diagnostic (CDx) Panel
Sponsored Test1 Gene
Frontotemporal Dementia Sponsored Testing Program
Sponsored Test1 Gene
X-linked Adrenoleukodystrophy (X-ALD) Newborn Screening Reflex Test Program
Sponsored Test1 Gene
Peroxisomal Biogenesis Disorder-Zellweger Spectrum Disorder (PBD-ZSD) Test Program
Sponsored Test1 Gene
Early-Onset Bilateral Cataracts Genetic Test Program
Sponsored Test1 Gene
Cholestasis Genetic Test Program
Sponsored Test1 Gene
Movement Disorder Genetic Test Program
Sponsored Test1 Gene
Decode DEB Sponsored Testing Program
Sponsored Test1 Gene
Familial Chylomicronemia Syndrome (FCS) Testing Program
Sponsored Test1 Gene
Amyotrophic Lateral Sclerosis (ALS) Testing Program
Sponsored Test1 Gene
ABCC6 Deficiency Genetic Test Program
Sponsored Test1 Gene
ENPP1 and ABCC6 Genetic Testing (SP‑051)
Sponsored Test1 Gene
My Retina Tracker Program
Sponsored Test1 Gene
DetectHypopara™ Sponsored Testing Program
Sponsored Test1 Gene